{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:01Z","timestamp":1794270121464,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020439","name":"Jiangsu Pharmaceutical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107980","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:44:53Z","timestamp":1787849093000},"page":"107980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host inflammation drives low-exposure nephrotoxicity in critically ill patients receiving polymyxin B: A prospective study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4448-4882","authenticated-orcid":false,"given":"Xuemei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7113-3694","authenticated-orcid":false,"given":"Weihong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107980_bib0001","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12879-017-2471-0","article-title":"Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality","volume":"17","author":"Li","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-030-16373-0_14","article-title":"Clinical use of polymyxin B","volume":"1145","author":"Rigatto","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0003","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/jac\/dkq285","article-title":"The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic","volume":"65","author":"Elias","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0004","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1128\/AAC.00844-15","article-title":"Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant gram-negative rods","volume":"59","author":"Nelson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0005","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/jac\/dku561","article-title":"Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study","volume":"70","author":"Rigatto","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0007","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/microorganisms8111814","article-title":"Performance of population pharmacokinetic models in predicting polymyxin B exposures","volume":"8","author":"Tam","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105328","article-title":"Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury","volume":"163","author":"Sisay","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107844","article-title":"Predictive factors for 30-day mortality after polymyxin B treatment of carbapenem-resistant gram-negative bacilli infections","volume":"154","author":"Zhou","year":"2025","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0010","doi-asserted-by":"crossref","first-page":"e01900","DOI":"10.1128\/AAC.01900-20","article-title":"Comparing the population pharmacokinetics of and acute kidney injury due to polymyxin B in Chinese patients with or without renal insufficiency","volume":"65","author":"Wang","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0011","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13054-022-04195-7","article-title":"An area under the concentration-time curve threshold as a predictor of efficacy and nephrotoxicity for individualizing polymyxin B dosing in patients with carbapenem-resistant gram-negative bacteria","volume":"26","author":"Yang","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118432","article-title":"The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets","volume":"10","author":"Saito","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2021.07.033","article-title":"Differentiation of active corneal infections from healed scars using deep learning","volume":"129","author":"Tiwari","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0014","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.spinee.2021.02.007","article-title":"Using a national surgical database to predict complications following posterior lumbar surgery and comparing the area under the curve and F1-score for the assessment of prognostic capability","volume":"21","author":"DeVries","year":"2021","journal-title":"Spine J"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ndt\/gfp392","article-title":"Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury","volume":"25","author":"Bouchard","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00228-020-02986-x","article-title":"Estimation of the area under concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia","volume":"77","author":"Chen","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0017","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4155\/bio-2020-0051","article-title":"Therapeutic drug monitoring of polymyxin B by LC-MS\/MS in plasma and urine","volume":"12","author":"Liu","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0018","article-title":"Dosing and pharmacokinetics of polymyxin B in patients with renal insufficiency","volume":"61","author":"Thamlikitkul","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0019","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cpt.981","article-title":"Population pharmacokinetics of polymyxin B","volume":"104","author":"Manchandani","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00792-21","article-title":"Pharmacokinetics of polymyxin B in hospitalized adults with cystic fibrosis","volume":"65","author":"Crass","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/crj.13493","article-title":"Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients","volume":"16","author":"Ye","year":"2022","journal-title":"Clin Respir J"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115291","article-title":"Determination of polymyxin B in human plasma and epithelial lining fluid using LC-MS\/MS and its clinical application in therapeutic drug monitoring","volume":"227","author":"Zhang","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0023","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13054-023-04522-6","article-title":"Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial","volume":"27","author":"Liu","year":"2023","journal-title":"Crit Care (London, England),"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0024","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026684118","article-title":"Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury","volume":"118","author":"Gerhardt","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2026.107980_bib0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/apha.12764","article-title":"Biomarkers in acute kidney injury\u2013pathophysiological basis and clinical performance","volume":"219","author":"Schrezenmeier","year":"2017","journal-title":"Acta Physiol (Oxf)"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:36:07Z","timestamp":1794267367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002670"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107980","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host inflammation drives low-exposure nephrotoxicity in critically ill patients receiving polymyxin B: A prospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107980"}}